Loading...
Loading...
Application UK00918091202 · Registered

| Application Number | UK00918091202 |
| Status | Registered |
| Owner | AEC COSMETICS USA, INC. |
| Filed | 2019-07-08 |
| Registered | 2019-12-21 |
| Renewal Due | 2029-07-08 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Yes. XTRALANE is currently a registered UK trademark, with renewal due on 2029-07-08. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Surgical implants comprised of artificial materials; Bone implants composed of artificial materials; Artificial organs and implants; Silicone prosthetic implants; Artificial breast implants; Biodegradable implants.
Advertising; Business management; Business administration; Office functions; Import and export services; Franchising, namely consultancy and assistance with business management, organisation and promotion relating to commercial and/or industrial management assistance; Wholesale, retail store services, via catalogues, as well as via global computer networks, of implants, surgical instruments, cosmetology.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
'XTRALANE' is a registered trademark on the UK IPO register, owned by AEC COSMETICS USA, INC.. The application (UK00918091202) was filed on 8 July 2019 and registered on 21 December 2019. The registration is set to expire on 8 July 2029.
This mark is recorded under multiple classes: Class 10 (medical & surgical apparatus); Class 35 (advertising, business management & retail services).
The trademark is represented by Page, White & Farrer Limited.
UK trademark UK00918091202 for the mark 'XTRALANE' in Class 10, 35 is recorded on the UK IPO register as owned by AEC COSMETICS USA, INC.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00918091202 for the mark 'XTRALANE' as registered.
UK trademark UK00918091202 for the mark 'XTRALANE' is recorded in Class 10 (medical & surgical apparatus); Class 35 (advertising, business management & retail services). The filed specification reads: Class 10: Surgical implants comprised of artificial materials; Bone implants composed of artificial materials; Artificial organs and implants; Silicone prosthetic implants; Artificial breast implants; Biodegradable implants. | Class 35: Advertising; Business management; Business administration; Office functions; Imp…
UK trademark UK00918091202 for the mark 'XTRALANE' was filed at the UK IPO on 8 July 2019 and registered on 21 December 2019.
UK trademark UK00918091202 for the mark 'XTRALANE' is currently recorded as valid until 8 July 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Page, White & Farrer Limited is listed as the attorney / representative of record for UK trademark UK00918091202 for the mark 'XTRALANE' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.